<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font26">the </span>
   <span class="font18">[]. </span>
   <span class="font17">for </span>
   <span class="font17">with </span>
   <span class="font14">COVID- </span>
   <span class="font14">SARS-CoV- </span>
   <span class="font13">patients </span>
   <span class="font13">are </span>
   <span class="font12">that </span>
   <span class="font12">treatment </span>
   <span class="font12">The </span>
   <span class="font12">clinical </span>
   <span class="font12">viral </span>
   <span class="font11">against </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">cells </span>
   <span class="font11">virus </span>
   <span class="font11">from </span>
   <span class="font11">coronavirus </span>
   <span class="font11">severe </span>
   <span class="font11">has </span>
   <span class="font11">was </span>
   <span class="font11">immune </span>
   <span class="font11">infection </span>
   <span class="font11">respiratory </span>
   <span class="font11">NCT, </span>
   <span class="font11">RNA </span>
   <span class="font11">been </span>
   <span class="font11">protein </span>
   <span class="font11">including </span>
   <span class="font11">have </span>
   <span class="font11">human </span>
   <span class="font11">its </span>
   <span class="font11">disease </span>
   <span class="font11">not </span>
   <span class="font11">{background </span>
   <span class="font11">which </span>
   <span class="font11">antiviral </span>
   <span class="font11">plasma </span>
   <span class="font11">potential </span>
   <span class="font11">therapy </span>
   <span class="font11">cell </span>
   <span class="font10">antibodies </span>
   <span class="font10">can </span>
   <span class="font10">chloroquine </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">receptor </span>
   <span class="font10">activity </span>
   <span class="font10">efficacy </span>
   <span class="font10">syndrome </span>
   <span class="font10">use </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">convalescent </span>
   <span class="font10">margin </span>
   <span class="font10">online: </span>
   <span class="font10">trial </span>
   <span class="font10">were </span>
   <span class="font10">study </span>
   <span class="font10">vitro </span>
   <span class="font10">{border-style </span>
   <span class="font10">SARS </span>
   <span class="font10">other </span>
   <span class="font10">reported </span>
   <span class="font10">studies </span>
   <span class="font10">used </span>
   <span class="font10">IL- </span>
   <span class="font10">Patients </span>
   <span class="font10">acute </span>
   <span class="font10">associated </span>
   <span class="font10">px;} </span>
   <span class="font10">who </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">However, </span>
   <span class="font10">[,]. </span>
   <span class="font10">[], </span>
   <span class="font10">administration </span>
   <span class="font10">combination </span>
   <span class="font10">infected </span>
   <span class="font10">monoclonal </span>
   <span class="font10">replication </span>
   <span class="font10">trials </span>
   <span class="font10">COVID-: </span>
   <span class="font10">China </span>
   <span class="font10">Respiratory </span>
   <span class="font10">Treatment </span>
   <span class="font10">antibody </span>
   <span class="font10">cytokine </span>
   <span class="font10">host </span>
   <span class="font10">protease </span>
   <span class="font10">risk </span>
   <span class="font10">spike </span>
   <span class="font10">virus, </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Clinical </span>
   <span class="font10">Infect. </span>
   <span class="font10">Med. </span>
   <span class="font10">also </span>
   <span class="font10">day </span>
   <span class="font10">demonstrated </span>
   <span class="font10">effective </span>
   <span class="font10">more </span>
   <span class="font10">proteins </span>
   <span class="font10">remdesivir </span>
   <span class="font10">response </span>
   <span class="font10">showed </span>
   <span class="font10">two </span>
   <span class="font10">FDA </span>
   <span class="font10">IVIG </span>
   <span class="font10">LPV/r </span>
   <span class="font10">NCT </span>
   <span class="font10">al. </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">days </span>
   <span class="font10">drugs </span>
   <span class="font10">effects </span>
   <span class="font10">influenza </span>
   <span class="font10">mortality </span>
   <span class="font10">than </span>
   <span class="font10">well </span>
   <span class="font10">ACE </span>
   <span class="font10">Immune </span>
   <span class="font10">Severe </span>
   <span class="font10">binding </span>
   <span class="font10">but </span>
   <span class="font10">cytokines </span>
   <span class="font10">into </span>
   <span class="font10">neutralizing </span>
   <span class="font10">several </span>
   <span class="font10">therapeutic </span>
   <span class="font10">this </span>
   <span class="font10">East </span>
   <span class="font10">approved </span>
   <span class="font10">arbidol </span>
   <span class="font10">between </span>
   <span class="font10">due </span>
   <span class="font10">lung </span>
   <span class="font10">viruses </span>
   <span class="font10">Acute </span>
   <span class="font10">Middle </span>
   <span class="font10">azithromycin </span>
   <span class="font10">drug </span>
   <span class="font10">factor </span>
   <span class="font10">favipiravir </span>
   <span class="font10">inhibition </span>
   <span class="font10">novel </span>
   <span class="font10">patients, </span>
   <span class="font10">pro-inflammatory </span>
   <span class="font10">their </span>
   <span class="font10">these </span>
   <span class="font10">three </span>
   <span class="font10">August </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Disease </span>
   <span class="font10">Syndrome </span>
   <span class="font10">after </span>
   <span class="font10">hospitalized </span>
   <span class="font10">inhibitor </span>
   <span class="font10">may </span>
   <span class="font10">mesylate </span>
   <span class="font10">oxide </span>
   <span class="font10">results </span>
   <span class="font10">ribavirin </span>
   <span class="font10">safety </span>
   <span class="font10">specific </span>
   <span class="font10">such </span>
   <span class="font10">while </span>
   <span class="font10">... </span>
   <span class="font10">Clin. </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Plasma </span>
   <span class="font10">Review </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">adverse </span>
   <span class="font10">analysis </span>
   <span class="font10">both </span>
   <span class="font10">cells, </span>
   <span class="font10">compared </span>
   <span class="font10">first </span>
   <span class="font10">fusion </span>
   <span class="font10">hepatitis </span>
   <span class="font10">higher </span>
   <span class="font10">important </span>
   <span class="font10">increased </span>
   <span class="font10">infections </span>
   <span class="font10">inhibits </span>
   <span class="font10">involved </span>
   <span class="font10">levels </span>
   <span class="font10">receptors </span>
   <span class="font10">reduced </span>
   <span class="font10">registered </span>
   <span class="font10">responsible </span>
   <span class="font10">shown </span>
   <span class="font10">targeting </span>
   <span class="font10">using </span>
   <span class="font10">â€" </span>
   <span class="font10">(.%) </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">For </span>
   <span class="font10">Health </span>
   <span class="font10">RBD </span>
   <span class="font10">Viral </span>
   <span class="font10">action </span>
   <span class="font10">anti-viral </span>
   <span class="font10">concentrations </span>
   <span class="font10">critically </span>
   <span class="font10">effect </span>
   <span class="font10">four </span>
   <span class="font10">high </span>
   <span class="font10">highly </span>
   <span class="font10">inhibit </span>
   <span class="font10">innate </span>
   <span class="font10">likely </span>
   <span class="font10">mechanisms </span>
   <span class="font10">membrane </span>
   <span class="font10">most </span>
   <span class="font10">nitric </span>
   <span class="font10">polymerase </span>
   <span class="font10">promising </span>
   <span class="font10">px; </span>
   <span class="font10">release </span>
   <span class="font10">responses </span>
   <span class="font10">review </span>
   <span class="font10">role </span>
   <span class="font10">serine </span>
   <span class="font10">structure </span>
   <span class="font10">treat </span>
   <span class="font10">type </span>
   <span class="font10">when </span>
   <span class="font10">{font-family </span>
   <span class="font10">.%), </span>
   <span class="font10">Administration </span>
   <span class="font10">Anti-viral </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Convalescent </span>
   <span class="font10">Ebola </span>
   <span class="font10">Engl. </span>
   <span class="font10">July </span>
   <span class="font10">MERS </span>
   <span class="font10">NIH </span>
   <span class="font10">Response </span>
   <span class="font10">Several </span>
   <span class="font10">Similarly, </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">Therapy </span>
   <span class="font10">There </span>
   <span class="font10">This </span>
   <span class="font10">Virol../jmv. </span>
   <span class="font10">activation </span>
   <span class="font10">antigen </span>
   <span class="font10">children </span>
   <span class="font10">chronic </span>
   <span class="font10">considered </span>
   <span class="font10">could </span>
   <span class="font10">data </span>
   <span class="font10">different </span>
   <span class="font10">domain </span>
   <span class="font10">font-size </span>
   <span class="font10">ill </span>
   <span class="font10">immunity </span>
   <span class="font10">improved </span>
   <span class="font10">inflammatory </span>
   <span class="font10">intravenous </span>
   <span class="font10">large </span>
   <span class="font10">less </span>
   <span class="font10">mAbs </span>
   <span class="font10">one </span>
   <span class="font10">panel </span>
   <span class="font10">pneumonia </span>
   <span class="font10">potent </span>
   <span class="font10">proteases </span>
   <span class="font10">recommended </span>
   <span class="font10">single </span>
   <span class="font10">target </span>
   <span class="font10">there </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">-nCoV </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Arbidol </span>
   <span class="font10">COVID-Available </span>
   <span class="font10">Care </span>
   <span class="font10">Dexamethasone </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">Immunoglobulin </span>
   <span class="font10">Nafamostat </span>
   <span class="font10">Nitric </span>
   <span class="font10">Novel </span>
   <span class="font10">Res../j.antiviral.. </span>
   <span class="font10">Use </span>
   <span class="font10">Vero </span>
   <span class="font10">With </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">adults </span>
   <span class="font10">alone </span>
   <span class="font10">another </span>
   <span class="font10">available </span>
   <span class="font10">camostat </span>
   <span class="font10">cases </span>
   <span class="font10">comorbidities </span>
   <span class="font10">complex </span>
   <span class="font10">confirmed </span>
   <span class="font10">dendritic </span>
   <span class="font10">dose </span>
   <span class="font10">double; </span>
   <span class="font10">duration </span>
   <span class="font10">during </span>
   <span class="font10">envelope </span>
   <span class="font10">evidence </span>
   <span class="font10">guidelines </span>
   <span class="font10">https://clinicaltrials.gov/ct/show/NCT(accessed </span>
   <span class="font10">humanized </span>
   <span class="font10">identified </span>
   <span class="font10">improvement </span>
   <span class="font10">infection, </span>
   <span class="font10">inflammation </span>
   <span class="font10">inhibiting </span>
   <span class="font10">interactions </span>
   <span class="font10">main </span>
   <span class="font10">major </span>
   <span class="font10">management </span>
   <span class="font10">molecular </span>
   <span class="font10">multiple </span>
   <span class="font10">nafamostat </span>
   <span class="font10">outcomes </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">patient </span>
   <span class="font10">people </span>
   <span class="font10">randomized </span>
   <span class="font10">required </span>
   <span class="font10">resulting </span>
   <span class="font10">side </span>
   <span class="font10">significant </span>
   <span class="font10">similar </span>
   <span class="font10">structural </span>
   <span class="font10">symptoms </span>
   <span class="font10">through </span>
   <span class="font10">time </span>
   <span class="font10">times </span>
   <span class="font10">transcription </span>
   <span class="font10">transfusion </span>
   <span class="font10">twice </span>
   <span class="font10">widely </span>
   <span class="font10">Î¼M) </span>
   <span class="font10">(EC </span>
   <span class="font10">(â€"%), </span>
   <span class="font10">.collab: </span>
   <span class="font10">Agents </span>
   <span class="font10">Agents./j.ijantimicag.. </span>
   <span class="font10">Although </span>
   <span class="font10">Another </span>
   <span class="font10">Azithromycin </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Control </span>
   <span class="font10">During </span>
   <span class="font10">Human </span>
   <span class="font10">IFN </span>
   <span class="font10">ISRCTN, </span>
   <span class="font10">Infection </span>
   <span class="font10">June </span>
   <span class="font10">MERS-CoV, </span>
   <span class="font10">Medicine </span>
   <span class="font10">NSP </span>
   <span class="font10">Potential </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Responses </span>
   <span class="font10">Rev. </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">United </span>
   <span class="font10">Virus </span>
   <span class="font10">able </span>
   <span class="font10">about </span>
   <span class="font10">agents </span>
   <span class="font10">al.A </span>
   <span class="font10">among </span>
   <span class="font10">anti </span>
   <span class="font10">arthritis </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">care </span>
   <span class="font10">chloroquine, </span>
   <span class="font10">clearance </span>
   <span class="font10">cohort </span>
   <span class="font10">concentration </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">currently </span>
   <span class="font10">developing </span>
   <span class="font10">diseases </span>
   <span class="font10">emergency </span>
   <span class="font10">entry </span>
   <span class="font10">enzyme </span>
   <span class="font10">epithelial </span>
   <span class="font10">expression </span>
   <span class="font10">five </span>
   <span class="font10">genome </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">interferon </span>
   <span class="font10">intermediate </span>
   <span class="font10">investigating </span>
   <span class="font10">ivermectin </span>
   <span class="font10">lack </span>
   <span class="font10">leading </span>
   <span class="font10">lymphocytes </span>
   <span class="font10">mechanism </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">might </span>
   <span class="font10">necrosis </span>
   <span class="font10">nuclear </span>
   <span class="font10">nucleocapsid </span>
   <span class="font10">number </span>
   <span class="font10">option </span>
   <span class="font10">pathogen </span>
   <span class="font10">possible </span>
   <span class="font10">production </span>
   <span class="font10">pulmonary </span>
   <span class="font10">recovered </span>
   <span class="font10">reduce </span>
   <span class="font10">reducing </span>
   <span class="font10">regulatory </span>
   <span class="font10">released </span>
   <span class="font10">retrospective </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">significantly </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">storm </span>
   <span class="font10">support </span>
   <span class="font10">systematic </span>
   <span class="font10">targets </span>
   <span class="font10">therapies </span>
   <span class="font10">treating </span>
   <span class="font10">ventilation </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(hypertension </span>
   <span class="font10">-day </span>
   <span class="font10">ARDS </span>
   <span class="font10">Acad. </span>
   <span class="font10">COVID-J. </span>
   <span class="font10">CRS </span>
   <span class="font10">Camostat </span>
   <span class="font10">Despite </span>
   <span class="font10">Drug </span>
   <span class="font10">HIV- </span>
   <span class="font10">Hospitalized </span>
   <span class="font10">Host </span>
   <span class="font10">IL-, </span>
   <span class="font10">Interleukin- </span>
   <span class="font10">Intravenous </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">Japan </span>
   <span class="font10">Lopinavir/Ritonavir </span>
   <span class="font10">Med../NEJMoa </span>
   <span class="font10">Mesylate </span>
   <span class="font10">Oxide </span>
   <span class="font10">Protease </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">Res. </span>
   <span class="font10">Res../j.antiviral... </span>
   <span class="font10">Sci. </span>
   <span class="font10">Society </span>
   <span class="font10">Systematic </span>
   <span class="font10">Tocilizumab </span>
   <span class="font10">Transl. </span>
   <span class="font10">Trial </span>
   <span class="font10">Zika </span>
   <span class="font10">[,,]. </span>
   <span class="font10">acid </span>
   <span class="font10">activates </span>
   <span class="font10">adult </span>
   <span class="font10">affected </span>
   <span class="font10">al.Clinical </span>
   <span class="font10">amino </span>
   <span class="font10">angiotensin </span>
   <span class="font10">animal </span>
   <span class="font10">bat </span>
   <span class="font10">bind </span>
   <span class="font10">bold </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">cause </span>
   <span class="font10">caused </span>
   <span class="font10">cellular </span>
   <span class="font10">changing </span>
   <span class="font10">common </span>
   <span class="font10">control </span>
   <span class="font10">controlled </span>
   <span class="font10">converting </span>
   <span class="font10">courier; </span>
   <span class="font10">daily </span>
   <span class="font10">days) </span>
   <span class="font10">dexamethasone </span>
   <span class="font10">diabetes </span>
   <span class="font10">differentiation </span>
   <span class="font10">distress </span>
   <span class="font10">does </span>
   <span class="font10">effectively </span>
   <span class="font10">em; </span>
   <span class="font10">evaluating </span>
   <span class="font10">expressed </span>
   <span class="font10">failure </span>
   <span class="font10">family </span>
   <span class="font10">followed </span>
   <span class="font10">forms </span>
   <span class="font10">genes </span>
   <span class="font10">genomic </span>
   <span class="font10">guanosine </span>
   <span class="font10">health </span>
   <span class="font10">hospital </span>
   <span class="font10">humoral </span>
   <span class="font10">immunopathogenesis </span>
   <span class="font10">infection: </span>
   <span class="font10">interaction </span>
   <span class="font10">interferon-Î± </span>
   <span class="font10">laboratory-confirmed </span>
   <span class="font10">like </span>
   <span class="font10">load </span>
   <span class="font10">macrophages </span>
   <span class="font10">now </span>
   <span class="font10">open </span>
   <span class="font10">open-label </span>
   <span class="font10">organs </span>
   <span class="font10">oxygen </span>
   <span class="font10">particles </span>
   <span class="font10">ppa </span>
   <span class="font10">previous </span>
   <span class="font10">protective </span>
   <span class="font10">proven </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized, </span>
   <span class="font10">rapid </span>
   <span class="font10">received </span>
   <span class="font10">recent </span>
   <span class="font10">recombinant </span>
   <span class="font10">recommends </span>
   <span class="font10">related </span>
   <span class="font10">remdesivir, </span>
   <span class="font10">revealed </span>
   <span class="font10">same </span>
   <span class="font10">serious </span>
   <span class="font10">signaling </span>
   <span class="font10">similarity </span>
   <span class="font10">spectrum </span>
   <span class="font10">suggests </span>
   <span class="font10">synthesized </span>
   <span class="font10">system </span>
   <span class="font10">systemic </span>
   <span class="font10">tested </span>
   <span class="font10">toxicity </span>
   <span class="font10">transmission </span>
   <span class="font10">treated </span>
   <span class="font10">vs. </span>
   <span class="font10">without </span>
  </p>
 </body>
</html>
